Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. USO
8. HOOD
9. DFTX
10. RGNX

Go back to Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breas
(NASDAQ: ARVN) Delayed: 7.59 -0.08 (1.04%)
Previous Close $7.67    52 Week High $ 
Open $7.70    52 Week Low $ 
Day High $7.76    P/E N/A 
Day Low $7.48    EPS $ 
Volume 339,669       

Pfizer Inc. (NYSE: PFE) Delayed: 25.12 -0.09 (0.36%)
Previous Close $25.21    52 Week High $37.39 
Open $25.22    52 Week Low $28.25 
Day High $25.31    P/E 15.22 
Day Low $24.96    EPS $1.65 
Volume 19,255,328